Nathan J. Nordmann, M.D., Joins Baptist Health Miami Neuroscience Institute as Director of Spinal Oncology and Co-Director of Spinal Radiosurgery South Florida Hospital News
Fellowship-Trained Neuro-Oncologist Nishika Karbhari, M.D., Joins Baptist Health Herbert Wertheim Cancer Institute South Florida Hospital News
Spencer Streit, D.O., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist and Hematologist | Florida Hospital News and Healthcare Report South Florida Hospital News
Kriti Ahuja, M.D., Joins Baptist Health Wertheim Cancer Institute as a Breast Medical Oncologist South Florida Hospital News
In research published in the journal Nature, McGill University researchers looked at the relationship between diet, the gut microbiome and patient response to immune checkpoint blockade. To their surprise, certain diets often considered "unhealthy" or "fattening" were associated with better responses to a type of…
The Next Era of Breast Cancer Care: Penny Kechagioglou European Medical Journal
Новый реактор: увеличение поставок радиофармацевтических препаратов для лечения рака. Vietnam.vn
AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video markets.businessinsider.com
Исследование не выявило связи между семаглутидом и раком поджелудочной железы Life4me+
AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video StreetInsider
AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video FinancialContent
A 39-patient exploratory analysis reported 34.8 months’ median survival in pancreatic cancer. Stock Titan